Market openADR
GENFIT/$GNFT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GENFIT
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
Ticker
$GNFT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
180
ISIN
US3722791098
Website
GENFIT Metrics
BasicAdvanced
$211M
120.62
$0.03
1.07
-
Price and volume
Market cap
$211M
Beta
1.07
52-week high
$6.24
52-week low
$2.55
Average daily volume
19K
Financial strength
Current ratio
1.234
Quick ratio
1.189
Long term debt to equity
8.02
Total debt to equity
89.756
Interest coverage (TTM)
0.63%
Management effectiveness
Return on assets (TTM)
1.26%
Return on equity (TTM)
2.20%
Valuation
Price to earnings (TTM)
120.619
Price to revenue (TTM)
2.547
Price to book
2.77
Price to tangible book (TTM)
9.05
Price to free cash flow (TTM)
12.357
Growth
Revenue change (TTM)
105.72%
Earnings per share change (TTM)
-105.16%
3-year revenue growth (CAGR)
-5.98%
3-year earnings per share growth (CAGR)
-71.00%
What the Analysts think about GENFIT
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GENFIT stock.
GENFIT Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GENFIT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GENFIT News
AllArticlesVideos
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GlobeNewsWire·18 hours ago
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GlobeNewsWire·1 week ago
GENFIT to Present Latest ACLF Research at EASL Congress 2025
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GENFIT stock?
GENFIT (GNFT) has a market cap of $211M as of May 15, 2025.
What is the P/E ratio for GENFIT stock?
The price to earnings (P/E) ratio for GENFIT (GNFT) stock is 120.62 as of May 15, 2025.
Does GENFIT stock pay dividends?
No, GENFIT (GNFT) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next GENFIT dividend payment date?
GENFIT (GNFT) stock does not pay dividends to its shareholders.
What is the beta indicator for GENFIT?
GENFIT (GNFT) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.